Deal of The Day! Hurry Up, Grab the Special Discount - Save 25% - Ends In 00:00:00 Coupon code: SAVE25
Welcome to Pass4Success

- Free Preparation Discussions
Mail Us support@pass4success.com
Location US
Mob_nav_barsMENU

AMA PCM Exam - Topic 1 Question 67 Discussion

Saleye Pharmaceuticals develops cheaper alternatives to proprietary drugs. Its mission statement states that it wants to create affordable medicine for everyone and create a healthier world. Saleye releases a new and improved version of its pain-relieving drug, Fento. Within a week, Saleye receives many complaints stating that the drug is inducing hallucinations and in some cases triggering certain anxiety disorders. Saleye was caught off-guard as its animal and human trials did not reveal any side effects. Saleye deliberated over the decision to recall the drug for over a week and by the time it eventually did, it had lost millions in stocks. Where did Saleye fail?
D) It prioritized profits over effective drugs.
A) It did not have an ethical mission statement.
B) It did not have control measures in place.
C) It did not consider the target market before creating its drug.
E) It did not conduct large-scale human trials.

AMA PCM Exam - Topic 1 Question 67 Discussion

Actual exam question for AMA's PCM exam
Question #: 67
Topic #: 1
[All PCM Questions]

Saleye Pharmaceuticals develops cheaper alternatives to proprietary drugs. Its mission statement states that it wants to create affordable medicine for everyone and create a healthier world. Saleye releases a new and improved version of its pain-relieving drug, Fento. Within a week, Saleye receives many complaints stating that the drug is inducing hallucinations and in some cases triggering certain anxiety disorders. Saleye was caught off-guard as its animal and human trials did not reveal any side effects. Saleye deliberated over the decision to recall the drug for over a week and by the time it eventually did, it had lost millions in stocks. Where did Saleye fail?

Show Suggested Answer Hide Answer
Suggested Answer: D

by Judy at Mar 23, 2023, 08:37 AM

Limited Time Offer

25%

Off

Get Premium PCM Questions as Interactive Web-Based Practice Test or PDF

Contribute your Thoughts:

0/2000 characters
Submit Cancel
Merissa
8 months ago
Their mission statement sounds good, but actions speak louder!
upvoted 0 times
...
Fanny
8 months ago
They lacked proper control measures for sure.
upvoted 0 times
...
Geraldo
9 months ago
Hallucinations? That sounds a bit extreme...
upvoted 0 times
...
Chu
9 months ago
I think they prioritized profits over safety.
upvoted 0 times
...
Willodean
9 months ago
They definitely should've done larger trials!
upvoted 0 times
...
Roxanne
9 months ago
I wonder if they considered the target market before creating the drug. If they had, maybe they would have anticipated the potential for anxiety disorders in certain users.
upvoted 0 times
...
Kati
9 months ago
I feel like they prioritized profits over effective drugs. Their mission statement sounds good, but the delay in recalling Fento suggests they were more focused on financial loss than patient safety.
upvoted 0 times
...
Tamra
9 months ago
I'm not entirely sure, but maybe they didn't have control measures in place? I remember a case study that emphasized the importance of monitoring drug effects post-launch.
upvoted 0 times
...
Latrice
9 months ago
I think Saleye might have failed because they didn't conduct large-scale human trials. It seems like a crucial step that could have caught those side effects earlier.
upvoted 0 times
...
Hildred
9 months ago
I thought their mission statement was solid, but maybe it didn’t translate into their practices. It’s confusing how they missed these issues during trials.
upvoted 0 times
...
Janessa
9 months ago
This reminds me of a case study we did on a similar situation where a company prioritized profits. I wonder if that played a role in Saleye's decision-making.
upvoted 0 times
...
Yen
9 months ago
I’m not entirely sure, but I think they might have underestimated the need for large-scale human trials. That could explain the unexpected side effects.
upvoted 0 times
...
Lashawnda
9 months ago
I remember discussing the importance of control measures in drug development. It seems like Saleye really dropped the ball there.
upvoted 0 times
...
Charlette
9 months ago
I'm not totally sure about this one. I'll need to review the concepts around translation patterns and route patterns before deciding.
upvoted 0 times
...
Emiko
9 months ago
Hmm, I'm a bit unsure about this one. The options seem to cover different aspects of customer success, but I'm not sure which one is the "best" summary. I'll have to think this through.
upvoted 0 times
...
Douglass
10 months ago
If I recall correctly, the 0.0.0.0 address means any IP can connect, which is broader than just one specific IP like 1.2.3.4. But I'm not completely confident in that.
upvoted 0 times
...
Quentin
1 year ago
I think the answer is B - Saleye didn't have the proper control measures in place to catch these serious side effects before releasing the drug. Their animal and human trials were clearly not comprehensive enough.
upvoted 0 times
Leota
1 year ago
C) It did not consider the target market before creating its drug.
upvoted 0 times
...
Scot
1 year ago
B) It did not have control measures in place.
upvoted 0 times
...
Fabiola
1 year ago
A) It did not have an ethical mission statement.
upvoted 0 times
...
...
Sena
1 year ago
Haha, 'a healthier world'? More like a world of hallucinating patients! Saleye needs to go back to the drawing board and remember that 'affordable' doesn't mean 'cutting corners'.
upvoted 0 times
Sharan
1 year ago
C) It did not consider the target market before creating its drug.
upvoted 0 times
...
Brandon
1 year ago
B) It did not conduct large-scale human trials.
upvoted 0 times
...
Leota
1 year ago
A) It did not have control measures in place.
upvoted 0 times
...
...
Marge
1 year ago
This is a classic case of prioritizing profits over safety. Saleye should have put the wellbeing of patients first, instead of rushing an untested drug to market. Their mission statement rings hollow now.
upvoted 0 times
Mitzie
1 year ago
This is a classic case of prioritizing profits over safety. Saleye should have put the wellbeing of patients first, instead of rushing an untested drug to market. Their mission statement rings hollow now.
upvoted 0 times
...
Tegan
1 year ago
B) It did not conduct large-scale human trials.
upvoted 0 times
...
Tasia
1 year ago
A) It did not have control measures in place.
upvoted 0 times
...
...
Brandon
1 year ago
Saleye clearly dropped the ball on quality control and testing. Skimping on large-scale human trials was a huge oversight, and their greed for profits blinded them to the real-world consequences.
upvoted 0 times
Ahmed
1 year ago
D) It did not consider the target market before creating its drug.
upvoted 0 times
...
Lura
1 year ago
C) It prioritized profits over effective drugs.
upvoted 0 times
...
Callie
1 year ago
B) It did not conduct large-scale human trials.
upvoted 0 times
...
Nguyet
1 year ago
A) It did not have control measures in place.
upvoted 0 times
...
Hayley
1 year ago
C) It prioritized profits over effective drugs.
upvoted 0 times
...
Andra
1 year ago
B) It did not conduct large-scale human trials.
upvoted 0 times
...
Adolph
1 year ago
A) It did not have control measures in place.
upvoted 0 times
...
...
Billye
1 year ago
I agree with Colene. They should have had better monitoring in place to catch these side effects earlier.
upvoted 0 times
...
Colene
1 year ago
Yeah, it's really concerning. I think they failed because they didn't have control measures in place.
upvoted 0 times
...
Mertie
1 year ago
I can't believe Saleye Pharmaceuticals messed up with their new drug.
upvoted 0 times
...

Save Cancel